{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:21:15Z","timestamp":1790774475154,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007623","name":"School of Medicine, Emory University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007623","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ejmech.2020.112479","type":"journal-article","created":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T18:23:18Z","timestamp":1591467798000},"page":"112479","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Discovery of novel aminopiperidinyl amide CXCR4 modulators through virtual screening and rational drug design"],"prefix":"10.1016","volume":"201","author":[{"given":"Yoon Hyeun","family":"Oum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"Kell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Younghyoun","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongxing","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Burger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunsuk","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2020.112479_bib1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrd3859","article-title":"The GPCR Network: a large-scale collaboration to determine human GPCR structure and function","volume":"12","author":"Stevens","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2020.112479_bib2","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ejphar.2014.06.060","article-title":"\u201cChemokine receptors as therapeutic targets: why aren\u2019t there more drugs?\u201d","volume":"746","author":"Solari","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2020.112479_bib3","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nri2972","article-title":"Overcoming hurdles in developing successful drugs targeting chemokine receptors","volume":"11","author":"Schall","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejmech.2020.112479_bib4","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.drudis.2011.05.014","article-title":"Animal models of asthma: value, limitations and opportunities for alternative approaches","volume":"16","author":"Holmes","year":"2011","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2020.112479_bib5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3390\/v4020309","article-title":"Novel approaches to inhibit HIV entry","volume":"4","author":"Didigu","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2020.112479_bib6","doi-asserted-by":"crossref","first-page":"R188","DOI":"10.1186\/ar3158","article-title":"CXC chemokine receptor 4 expressed in T cells plays an important role in the development of collagen-induced arthritis","volume":"12","author":"Chung","year":"2010","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ejmech.2020.112479_bib7","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/ng1149","article-title":"Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease","volume":"34","author":"Hernandez","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejmech.2020.112479_bib8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.7150\/thno.5135","article-title":"Involvement of CXCR4\/CXCR7\/CXCL12 interactions in inflammatory bowel disease","volume":"3","author":"Werner","year":"2013","journal-title":"Theranostics"},{"key":"10.1016\/j.ejmech.2020.112479_bib9","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3858\/emm.2010.42.6.048","article-title":"Inhibitory effect of CXC chemokine receptor 4 antagonist AMD3100 on bleomycin induced murine pulmonary fibrosis","volume":"42","author":"Song","year":"2010","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ejmech.2020.112479_bib10","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.4049\/jimmunol.0801920","article-title":"CXCR4\/CXCL12 hyperexpression plays a pivotal role in the pathogenesis of lupus","volume":"182","author":"Wang","year":"2009","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ejmech.2020.112479_bib11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7150\/thno.5376","article-title":"Small molecule inhibitors of CXCR4","volume":"3","author":"Debnath","year":"2013","journal-title":"Theranostics"},{"key":"10.1016\/j.ejmech.2020.112479_bib12","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ejmech.2017.08.027","article-title":"An update on small molecules targeting CXCR4 as starting points for the development of anti-cancer therapeutics","volume":"139","author":"Grande","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112479_bib13","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1021\/jm200568c","article-title":"Drug discovery Research targeting the CXC chemokine receptor 4 (CXCR4)","volume":"55","author":"Choi","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112479_bib14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4155\/fmc.15.176","article-title":"Identification of novel 2-(1 H-indol-1-yl)-benzohydrazides CXCR4 ligands impairing breast cancer growth and motility","volume":"8","author":"Grande","year":"2016","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112479_bib15","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3390\/molecules24030550","article-title":"CCR5\/CXCR4 dual antagonism for the improvement of HIV infection therapy","volume":"24","author":"Grande","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2020.112479_bib16","doi-asserted-by":"crossref","first-page":"65109","DOI":"10.18632\/oncotarget.11371","article-title":"Ligand-activated PPAR\u03b3 downregulates CXCR4 gene expression through a novel identified PPAR response element and inhibits breast cancer progression","volume":"7","author":"Rovito","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2020.112479_bib17","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2174\/138161208783497714","article-title":"Small molecules anti-HIV therapeutics targeting CXCR4","volume":"14","author":"Grande","year":"2008","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejmech.2020.112479_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074548","article-title":"Preclinical development of a novel class of CXCR4 antagonist impairing solid tumors growth and metastases","volume":"8","author":"Portella","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.ejmech.2020.112479_bib19","first-page":"25","article-title":"Calcium signaling and cytotoxicity","volume":"107","author":"Kass","year":"1999","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.ejmech.2020.112479_bib20","first-page":"12","article-title":"Mitochondria death\/survival signaling pathways in cardiotoxicity induced by anthracyclines and anticancer-targeted therapies","author":"Montaigne","year":"2012","journal-title":"Biochem. Res. Internatl."},{"key":"10.1016\/j.ejmech.2020.112479_bib21","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nrd1134","article-title":"The bicyclam AMD3100 story","volume":"2","author":"De Clercq","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2020.112479_bib22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/14756360290024227","article-title":"Non-peptidic chemokine receptors antagonists as emerging anti-HIV agents","volume":"17","author":"Scozzafava","year":"2002","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112479_bib23","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1189\/jlb.0309132","article-title":"The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of pulmonary fibrosis","volume":"86","author":"Strieter","year":"2009","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.ejmech.2020.112479_bib24","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1517\/13543780903535867","article-title":"Anti-chemokine small molecule drugs: a promising future?","volume":"19","author":"Proudfoot","year":"2010","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.ejmech.2020.112479_bib25","series-title":"Methods in Enzymology","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0076-6879(09)05412-3","article-title":"Chapter 12 the use of receptor homology modeling to facilitate the design of selective chemokine receptor antagonists","author":"Carter","year":"2009"},{"key":"10.1016\/j.ejmech.2020.112479_bib26","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1021\/jm901530b","article-title":"Synthesis and Structure\u2212Activity relationships of azamacrocyclic C-X-C chemokine receptor 4 antagonists: analogues containing a single azamacrocyclic ring are potent inhibitors of T-cell tropic (X4) HIV-1 replication","volume":"53","author":"Bridger","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112479_bib27","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1016\/j.bmcl.2008.05.092","article-title":"Identification of novel non-peptide CXCR4 antagonists by ligand-based design approach","volume":"18","author":"Ueda","year":"2008","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112479_bib28","doi-asserted-by":"crossref","first-page":"7915","DOI":"10.1021\/jm801065q","article-title":"Orally bioavailable isothioureas block function of the chemokine receptor CXCR4 in\u00a0vitro and in\u00a0vivo","volume":"51","author":"Thoma","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112479_bib29","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.1194396","article-title":"Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists","volume":"330","author":"Wu","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2020.112479_bib30","doi-asserted-by":"crossref","first-page":"5517","DOI":"10.1073\/pnas.1120431109","article-title":"Structure-based ligand discovery for the protein\u2013protein interface of chemokine receptor CXCR4","volume":"109","author":"Mysinger","year":"2012","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.ejmech.2020.112479_bib31","doi-asserted-by":"crossref","first-page":"30155","DOI":"10.1038\/srep30155","article-title":"Discovery and characterization of novel small-molecule CXCR4 receptor agonists and antagonists","volume":"6","author":"Mishra","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2020.112479_bib32","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1128\/AAC.04654-14","article-title":"Insights into the mechanism of inhibition of CXCR4: identification of piperidinylethanamine analogs as anti-HIV-1 inhibitors","volume":"59","author":"Das","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.112479_bib33","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1021\/ci049714+","article-title":"ZINC--a free database of commercially available compounds for virtual screening","volume":"45","author":"Irwin","year":"2005","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2020.112479_bib34","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1021\/jm901137j","article-title":"New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays","volume":"53","author":"Baell","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112479_bib35","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1124\/mol.117.110940","article-title":"The bioactive protein-ligand conformation of GluN2C-selective positive allosteric modulators bound to the NMDA receptor","volume":"93","author":"Kaiser","year":"2018","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2020.112479_bib36","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1002\/cbic.201402056","article-title":"Anti-HIV small-molecule binding in the peptide subpocket of the CXCR4:CVX15 crystal structure","volume":"15","author":"Cox","year":"2014","journal-title":"Chembiochem"},{"key":"10.1016\/j.ejmech.2020.112479_bib37","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead- and drug-like compounds: the rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.ejmech.2020.112479_bib38","doi-asserted-by":"crossref","first-page":"5655","DOI":"10.1021\/jm070679i","article-title":"Discovery of small molecule CXCR4 antagonists","volume":"50","author":"Zhan","year":"2007","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112479_bib39","first-page":"47","article-title":"Methods of blood collection in the mouse","volume":"29","author":"Hoff","year":"2000","journal-title":"Lab animals"},{"key":"10.1016\/j.ejmech.2020.112479_bib40","doi-asserted-by":"crossref","first-page":"8556","DOI":"10.1021\/jm100786g","article-title":"Dipyrimidine amines: a novel class of chemokine receptor type 4 antagonists with high specificity","volume":"53","author":"Zhu","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112479_bib41","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nrd1549","article-title":"Docking and scoring in virtual screening for drug discovery: methods and applications","volume":"3","author":"Kitchen","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2020.112479_bib42","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1021\/jm0603365","article-title":"Comparison of shape-matching and docking as virtual screening tools","volume":"50","author":"Hawkins","year":"2007","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112479_bib43","doi-asserted-by":"crossref","first-page":"6582","DOI":"10.1021\/jm300687e","article-title":"Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking","volume":"55","author":"Mysinger","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112479_bib44","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1021\/jm990211i","article-title":"Synthesis and structure-activity relationships of phenylenebis(methylene)-linked bis-azamacrocycles that inhibit HIV-1 and HIV-2 replication by antagonism of the chemokine receptor CXCR4","volume":"42","author":"Bridger","year":"1999","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112479_bib45","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1128\/AAC.44.6.1667-1673.2000","article-title":"Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers","volume":"44","author":"Hendrix","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.112479_bib46","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.4049\/jimmunol.167.8.4686","article-title":"AMD3100, a potent and specific antagonist of the stromal cell-derived factor-1 chemokine receptor CXCR4, inhibits autoimmune joint inflammation in IFN-gamma receptor-deficient mice","volume":"167","author":"Matthys","year":"2001","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ejmech.2020.112479_bib47","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jmgm.2013.12.008","article-title":"Discovery of potent inhibitor for matrix metalloproteinase-9 by pharmacophore based modeling and dynamics simulation studies","volume":"49","author":"Kalva","year":"2014","journal-title":"J.\u00a0Mol. Graph. Model."},{"key":"10.1016\/j.ejmech.2020.112479_bib48","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112479_bib49","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1002\/prot.23106","article-title":"The VSGB 2.0 model: a next generation energy model for high resolution protein structure modeling","volume":"79","author":"Li","year":"2011","journal-title":"Proteins"},{"key":"10.1016\/j.ejmech.2020.112479_bib50","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/cmdc.201200582","article-title":"Benzenesulfonamides: a unique class of chemokine receptor Type 4 inhibitors","volume":"8","author":"Mooring","year":"2013","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2020.112479_bib51","article-title":"Development of a unique small molecule modulator of CXCR4","volume":"7","author":"Liang","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.ejmech.2020.112479_bib52","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1126\/science.1261064","article-title":"Structural biology. Crystal structure of the chemokine receptor CXCR4 in complex with a viral chemokine","volume":"347","author":"Qin","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2020.112479_bib53","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1021\/ci400037y","article-title":"Highly specific and sensitive pharmacophore model for identifying CXCR4 antagonists. Comparison with docking and shape-matching virtual screening performance","volume":"53","author":"Karaboga","year":"2013","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2020.112479_bib54","doi-asserted-by":"crossref","first-page":"14153","DOI":"10.1074\/jbc.M010429200","article-title":"Molecular interactions of cyclam and bicyclam non-peptide antagonists with the CXCR4 chemokine receptor","volume":"276","author":"Gerlach","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2020.112479_bib55","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0014-5793(03)00609-4","article-title":"Mutations at the CXCR4 interaction sites for AMD3100 influence anti-CXCR4 antibody binding and HIV-1 entry","volume":"546","author":"Hatse","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejmech.2020.112479_bib56","doi-asserted-by":"crossref","first-page":"27354","DOI":"10.1074\/jbc.M704739200","article-title":"Molecular mechanism of action of monocyclam versus bicyclam non-peptide antagonists in the CXCR4 chemokine receptor","volume":"282","author":"Rosenkilde","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2020.112479_bib57","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1124\/mol.108.049775","article-title":"Comparison of the potential multiple binding modes of bicyclam, monocylam, and noncyclam small-molecule CXC chemokine receptor 4 inhibitors","volume":"74","author":"Wong","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2020.112479_bib58","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1111\/j.1476-5381.2011.01551.x","article-title":"Pharmacological modulation of chemokine receptor function","volume":"165","author":"Scholten","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2020.112479_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jmgm.2015.05.004","article-title":"Studying the binding interactions of allosteric agonists and antagonists of the CXCR4 receptor","volume":"60","author":"Planesas","year":"2015","journal-title":"J.\u00a0Mol. Graph. Model."},{"key":"10.1016\/j.ejmech.2020.112479_bib60","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1021\/jm900133w","article-title":"Highly potent, orally available anti-inflammatory broad-spectrum chemokine inhibitors","volume":"52","author":"Fox","year":"2009","journal-title":"J.\u00a0Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420304505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420304505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:10:43Z","timestamp":1759327843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523420304505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":60,"alternative-id":["S0223523420304505"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112479","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of novel aminopiperidinyl amide CXCR4 modulators through virtual screening and rational drug design","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112479","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112479"}}